RAS components have numerous effects in the brain, and experimental evidence indicates that inhibiting the ACE/Ang-II/AT1R axis and stimulating the ACE2/Ang-(1-7)/MasR axis have positive effects in ischemic brain injury, particularly stroke. Here, MAS1L is linked to stroke disorder.